INORGANIC NANOMATERIALS PATH FROM DESIGN TO COMMERCIALIZATION
INORGANIC NANOMATERIALS PATH FROM DESIGN TO COMMERCIALIZATION
AviXéla empowers access to rapid design of nanomaterials for application testing, precision control over technical attributes for optimal performance, timely scale-up processes, and cost-effective and reproducible manufacturing systems to achieve meaningful commercial adoption.
PRECISION CONTROL OVER NANOMATERIALS SIZE AND TECHNICAL ATTRIBUTES TO MAXIMAZE PERFORMANCE
PROVEN ACCELERATED ABILITY TO SCALE UP NANOPARTICLES AND FLUID SYSTEMS COMPARE TO THEIR LABORATORY MADE COUNTERPARTS WHILE PRESERVING CRITICAL PROPERTIES
INFRASTRUCTURE DESIGNED TO ENSURE OUR CLIENTS CAN AQUIRE THE COST-EFFECTIVE NANOMATERIALS AT PILOT AND INDUSTRIAL SCALE VOLUMES
AviXéla employs its proprietary nanomaterials platform through innovative plasma-liquid system for nano-plasmonic elements and nanotechnology-based applications. Due to the multidisciplinary character of this field, NPs synthesis over the plasma-liquid interfaces presents important advantages, such as unnecessity of using reducing agents and organic solvents, simplicity of its experimental design, and continuous synthesis during plasma excitation.
Our team of researchers and engineers enables us to support the custom nanomaterial development from nanoparticle design and scale-up to its manufacturing and characterization. We aim to deliver cutting-edge in-house expertise in nanomaterials and custom-required time-intensive and cost reasonable products. We offer the advantages of one pot ultra-fast reaction synthesis with minimal waste production as compared to traditional wet chemistry synthesis techniques.
Due to the breadth of inorganic nanomaterials, we reconcile the use of alternate technology along with the use of renewable sources by coupling plasma on catalyst and catalyst on plasma in a pilot-scale device, capable to produce nanoparticles from any noble, alloy, and compound metal materials over the different interface substrates and residual solutions. Our manufacturing design ensures that nanomaterials made in the lab today can cost-effectively scale-up for manufacturing and commercialization.
Due to quantum properties of particles of matter with a diameter of 1 to 100 nanometers, they are commonly referred to as nanoparticles or ultrafine particles. Nanoparticles exhibit distinctive size-dependent features, mostly due to their small size and colossal surface area. The periodic boundary conditions of the crystalline particle are destroyed when the size of a particle approaches the nanoscale with the characteristic length scale close to or smaller than the de Broglie wavelength or the wavelength of light.
Because of this, many of the physical characteristics of nanoparticles differ significantly from those of bulk materials, leading to a wide range of their novel uses materials take on special properties at the nano (< 100 nm) scale that are not seen in their bulk counterparts. Variations in the size and compositions of these nanoparticles can broadly impact these properties and behaviors and can therefore be finely tuned and harnessed to tackle a wide range of product challenges.
With cutting-edge engineering experience, we could develop a consistently stable nanomaterials production to be effective due to the unique and distinct production system. Nevertheless, many nanomaterial companies focus on a single production material or limited set off-the-shelf materials, AviXéla integrate nanoplasmonic manufacturing challenging that rarely can be observed in the industry during a customer’s product development process. Our goal is to implement fundamental science and provide customers with access to the exact material specification they need to maximize the material’s performance and resolve their product integration challenges.
We empower nanomaterials manufacturing to synthesis cutting-edge NPs possesses chemicophysical properties such as nature, biocompatibility, anti-inflammatory and antibacterial activity, effective drug delivery, bioactivity, bioavailability, tumor targeting, and bio-absorption, which leading to a growth in the biotechnological, and applied microbiological applications.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.